Xcytrin motexafin gadolinium: Updated Phase II data

Updated preliminary data from 23 evaluable patients in an ongoing Phase II trial showed that 1 patient receiving Xcytrin plus Taxotere docetaxel had a partial remission and 17 had tumor stabilization...